Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.53.

  • Eton Pharmaceuticals' Asset Utilization Ratio fell 6852.98% to 0.53 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53, marking a year-over-year decrease of 6852.98%. This contributed to the annual value of 0.72 for FY2024, which is 3511.12% down from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Asset Utilization Ratio stood at 0.53, which was down 6852.98% from 0.46 recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Asset Utilization Ratio registered a high of 1.82 during Q1 2024, and its lowest value of 0.41 during Q1 2025.
  • For the 5-year period, Eton Pharmaceuticals' Asset Utilization Ratio averaged around 0.89, with its median value being 0.74 (2022).
  • Per our database at Business Quant, Eton Pharmaceuticals' Asset Utilization Ratio skyrocketed by 539733.18% in 2021 and then crashed by 7742.83% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.81 in 2021, then increased by 0.52% to 0.81 in 2022, then skyrocketed by 110.81% to 1.71 in 2023, then tumbled by 59.28% to 0.7 in 2024, then decreased by 23.69% to 0.53 in 2025.
  • Its last three reported values are 0.53 in Q3 2025, 0.46 for Q2 2025, and 0.41 during Q1 2025.